Trial: 201808178

A Phase II study of chemotherapy and immune checkpoint blockade with Pembrolizumab in the perioperative and maintenance treatment of locoregional gastric or GE junction adenocarcinoma.

Phase

II (Cancer Control)

Principal Investigator

Park, Haeseong

Disease Site

Stomach

Learn more about this study at: clinicaltrials.gov